Search Results - "EL Rosa"

  • Showing 1 - 17 results of 17
Refine Results
  1. 1

    OUTCOMES OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN ACUTE MYELOID LEUKEMIA PATIENTS WITH ACTIVE REFRACTORY DISEASE BEFORE TRANSPLANT by FS Azevedo, VC Molla, PHA Moraes, EL Rosa, RS Szor, CC Justino, CD Liz, AM Fonseca, C Arrais

    Published in Hematology, Transfusion and Cell Therapy (01-10-2024)
    “…Introduction: Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) is the most potent post-remission treatment for Acute Myeloid Leukemia (AML) to reduce…”
    Get full text
    Journal Article
  2. 2

    PROGNOSTIC IMPACT OF CYTOGENETIC ABNORMALITIES AND R2-ISS IN MULTIPLE MYELOMA by LS Abreu, ML Puls, RAF Machado, TFN Araújo, CD Liz, PHA Moraes, RS Szor, EL Rosa, VC Molla, CA Rodrigues

    Published in Hematology, Transfusion and Cell Therapy (01-10-2024)
    “…Introduction: Cytogenetic abnormalities are crucial for risk stratification and therapeutic decisions in multiple myeloma (MM). The incorporation of 1q+ into…”
    Get full text
    Journal Article
  3. 3

    HCT-CI AS A PREDICTOR OF ICU ADMISSION: BRAZILIAN SINGLE-CENTER COHORT STUDY by PPF Machado, AD Americo, EL Rosa, GGM Lima, JUA Filho, FPS Santos, BM Gusmão, FR Kerbauy, P Scheinberg

    Published in Hematology, Transfusion and Cell Therapy (01-10-2023)
    “…Introduction: MM is the leading indication for Autologous Stem Cell Transplantation (ASCT) globally. Although it is a safe procedure, it might be accompanied…”
    Get full text
    Journal Article
  4. 4

    ADULT T-CELL LEUKEMIA/LYMPHOMA RELAPSED AFTER AUTOLOGOUS TRANSPLANT AND TREATED WITH HAPLOIDENTICAL STEM CELL TRANSPLANT by TFN Araújo, LPDS Rocha, CF Oliveira, BA Souza, CFM Ferreira, LS Abreu, RAF Machado, ML Puls, PHA Moraes, EL Rosa, CD Liz, RS Szor, VC Molla, C Arrais

    Published in Hematology, Transfusion and Cell Therapy (01-10-2024)
    “…Introduction: Adult T-cell Leukemia/Lymphoma (ATL) is a highly aggressive T-cell malignancy that occurs in a proportion of individuals who are long-term…”
    Get full text
    Journal Article
  5. 5

    ENCOURAGING OUTCOMES OF SECOND ALLOGENEIC STEM CELL TRANSPLANT FOR ACUTE LEUKEMIAS AND MYELODYSPLASTIC SYNDROMES FROM TWO CENTERS IN SÃO PAULO, BRAZIL by EL Rosa, FS Azevedo, CC Justino, AM Fonseca, PHA Moraes, VC Molla, RS Szor, CD Liz, AG Guerra, MM Almeida, GMC Silva, CF Oliveira, TFN Araújo, LPDS Rocha, ML Puls, C Arrais

    Published in Hematology, Transfusion and Cell Therapy (01-10-2024)
    “…Objectives: Second allogeneic Hematopoietic Stem Cell Transplant (HSCT) is the only curative treatment option for patients who relapse after a first transplant…”
    Get full text
    Journal Article
  6. 6

    HIGH SURVIVAL RATES IN ELDERLY PATIENTS UNDERGOING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN SÃO PAULO, BRAZIL by CC Justino, FS Azevedo, EL Rosa, PHA Moraes, AM Fonseca, CD Liz, RS Szor, VC Molla, AG Guerra, CF Oliveira, TFN Araújo, GMC Silva, MM Almeida, LPDS Rocha, ML Puls, C Arrais

    Published in Hematology, Transfusion and Cell Therapy (01-10-2024)
    “…Objectives: Many hematological diseases, such as Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS) commonly affect individuals diagnosed in…”
    Get full text
    Journal Article
  7. 7

    Thematic Geovisualization of the Data Profile of Kaligesing, Purworejo, Central Java by Sudaryatno, Sudaryatno, El-Yasha, Shafiera Rosa, 'Afifah, Zulfa Nur'aini

    Published in Forum Geografi (27-12-2019)
    “…The scientific field has a variety of purposes, one of which is the presentation of data and information which can be used by other parties to support their…”
    Get full text
    Journal Article
  8. 8

    SÍNDROME MIELODISPLÁSICA SECUNDÁRIA A TERAPIA COM MUTAÇÃO TP53 APÓS TRATAMENTO DE MIELOMA MÚLTIPLO – RELATO DE CASO by CFM Ferreira, BA Souza, LS Abreu, RAF Machado, EL Rosa, PHA Moraes, VC Molla, RS Szor, CD Liz, C Arrais-Rodrigues

    Published in Hematology, Transfusion and Cell Therapy (01-10-2024)
    “…Introdução: A síndrome mielodisplásica secundária a terapia (SMDt) constitui cerca de 10-20% de todas as síndromes mielodisplásicas (SMD) e tende a apresentar…”
    Get full text
    Journal Article
  9. 9

    TRANSPLANTE DE CORDÃO UMBILICAL EM ADULTOS EM SERVIÇO PÚBLICO UNIVERSITÁRIO NOS ÚLTIMOS 5 ANOS by AG Guerra, GMC Silva, MM Almeida, CC Justino, PHA Moraes, EL Rosa, FDS Azevedo, AMRF Hial, VC Molla, C Arrais-Rodrigues

    Published in Hematology, Transfusion and Cell Therapy (01-10-2024)
    “…Objetivo: Descrição de casos de Transplante de Sangue de Cordão Umbilical (TSCU) para neoplasias hematológicas. Material e método: Estudo descritivo,…”
    Get full text
    Journal Article
  10. 10

    SEGUNDO TRANSPLANTE ALOGÊNICO EM PACIENTE COM LEUCEMIA LINFOBLÁSTICA AGUDA RECAÍDA E APÓS TERAPIA COM CÉLULAS CAR-T by AG Guerra, GMC Silva, MM Almeida, CC Justino, PHA Moraes, EL Rosa, FDS Azevedo, AMRF Hial, VC Molla, C Arrais-Rodrigues

    Published in Hematology, Transfusion and Cell Therapy (01-10-2024)
    “…Introdução: A LLA B com fusão BCR::ABL1 (LLA B Ph+) é mais prevalente entre pacientes mais idosos e historicamente associada a alto risco de recaída. O uso de…”
    Get full text
    Journal Article
  11. 11

    ALENTUZUMABE ASSOCIADO A CICLOSPORINA E ELTROMBOPAGUE EM PRIMEIRA LINHA PARA ANEMIA APLÁSICA MUITO GRAVE (AAMG): RELATO DE CASO by RAF Machado, ML Puls, BA Souza, CFM Ferreira, EL Rosa, CD Liz, PHA Moraes, RS Szor, VC Molla, C Arrais-Rodrigues

    Published in Hematology, Transfusion and Cell Therapy (01-10-2024)
    “…Objetivo: Descrição de caso de tratamento de primeira linha para anemia aplásica muito grave (AAMG) com alentuzumabe como estratégia de linfodepleção. Métodos:…”
    Get full text
    Journal Article
  12. 12

    ANÁLISE COMPARATIVA DA ESTRATIFICAÇÃO DE RISCO, DISPONIBILIDADE DE MEDICAMENTOS E DESFECHOS ENTRE PACIENTES COM LLC TRATADOS EM DOIS HOSPITAIS NA MESMA REGIÃO EM CONTEXTOS DISTINTOS (PÚBLICO E PRIVADO) by TFN Araújo, LPDS Rocha, CF Oliveira, ML Puls, CD Liz, EL Rosa, PHA Moraes, RS Szor, VC Molla, C Arrais

    Published in Hematology, Transfusion and Cell Therapy (01-10-2024)
    “…Introdução: A leucemia linfocítica crônica (LLC) é a leucemia mais comum em adultos no mundo ocidental, com média de idade ao diagnóstico de 70 anos, sendo…”
    Get full text
    Journal Article
  13. 13

    PRINCIPAIS ESTRATÉGIAS DE IDENTIFICAÇÃO E MANEJO DE SINTOMAS EM PACIENTES SUBMETIDOS A TERAPIA COM CÉLULAS T COM RECEPTOR DE ANTÍGENO QUIMÉRICO - CÉLULAS CAR - T: RELATO DE EXPERIÊNCIA by JL Teodoro, RM Correa, CAR Silva, FM Penachio, EL Rosa, JH Santile, MG Feitosa, JD Duarte, SF Pereira, LR Sabino

    Published in Hematology, Transfusion and Cell Therapy (01-10-2024)
    “…Objetivos: Relatar a experiência do serviço quanto às estratégias de identificação e manejo de sintomas após a infusão de células CAR-T. Material e métodos:…”
    Get full text
    Journal Article
  14. 14

    EMERGÊNCIA DE HEMOGLOBINÚRIA PAROXÍSTICA NOTURNA (HPN) HEMOLÍTICA NECESSITANDO TRATAMENTO COM ECULIZUMABE APÓS TRATAMENTO DE ANEMIA APLÁSTICA GRAVE COM IMUNOSSUPRESSÃO: RELATO DE CASO by LS Abreu, ML Puls, BA Souza, CFM Ferreira, EL Rosa, PHA Moraes, RS Szor, CD Liz, VC Molla, CA Rodrigues

    Published in Hematology, Transfusion and Cell Therapy (01-10-2024)
    “…Objetivo: Descrever a importância do acompanhamento do clone HPN em pacientes com anemia aplástica (AA) através de um relato de caso. Métodos: Relato de caso…”
    Get full text
    Journal Article
  15. 15

    Tunnel magnetoimpedance in cobalt discontinuous films by Schelp, L.F, Rosa, E.L, Maurice, J.-L, Petroff, F, Vaurès, A

    “…We present the impedance and its variation in magnetic fields for discontinuous Co films sandwiched by Al 2O 3. The Co nominal thickness varies from 0.7 to 2.5…”
    Get full text
    Journal Article
  16. 16
  17. 17